Competitive advantages of biopharmaceutical commodities in Bali province

Abstract

In the midst of a shift in people’s lifestyles that leads to an increasingly intensive use of herbal medicines, it has a positive impact on the existence of biopharmaceutical commodities that are increasingly economically valuable. This study aims to analyze (1) the leading biopharmaceutical commodities and (2) the competitive advantages of the biopharmaceutical commodities of the Province of Bali. The research was conducted in eight districts in the province of Bali. The number of respondents was determined using a purposive method, with a total of 160 respondents. Primary data collection was carried out through direct interviews with farmers using a questionnaire, while secondary data was collected from BPS-Statistics Indonesia. The location quotient (LQ) analysis is used to identify the top biopharmaceutical commodities, and the policy analysis matrix (PAM) method is used to study competitive advantage. The results showed that the leading biopharmaceutical commodity for Bali Province was turmeric, while ginger, galingale, galangal, and curcuma were not among the leading biopharmaceutical commodities. The results of the analysis using the PAM approach with the Private Cost Ratio indicator show that turmeric, ginger, galangal, galingale, and curcuma have competitive advantages.